The Efficacy of 24-Month Metformin for Improving Menses, Hormones, and Metabolic Profiles in Polycystic Ovary Syndrome

    Pei‐Chi Yang, Chih Yuan Hsu, Mei-Jou Chen, Mei Yu Lai, Zheng Rong Li, Chen Hsin Chen, Shee‐Uan Chen, Hong Nerng Ho
    Image of study
    TLDR Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.
    The study assessed the impact of metformin on 119 women with Polycystic Ovary Syndrome (PCOS) over a 24-month period, examining menstrual regularity, hormonal balance, and metabolic profiles. Metformin treatment led to increased menstrual frequency and decreased BMI, testosterone, and luteinizing hormone levels, particularly within the first 6 months. Notable improvements were seen in normal-weight women with high baseline testosterone and overweight women with normal testosterone levels. However, most parameters did not show sustained improvements beyond 6 months, except for a continued decline in free androgen index in normal-weight women. The study concluded that metformin is effective in improving menstrual and hormonal profiles in PCOS patients, with the greatest response seen by 6 months. The study faced limitations such as no control group and a high dropout rate, with only 37% of participants completing the full 24 months.
    View this study on academic.oup.com →

    Cited in this study

    Related